John F. Neylan, See Remarks at Angion Biomedica Corp. (ANGN), sold 363 shares at $13.91 ($5K) on 2021-05-18, disclosed to the SEC on 2021-05-19.
Scheduled sale ($5k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANGN | SELL | 2021-10-20 | $3K | — | Filing → |
| ANGN | SELL | 2021-09-21 | $4K | — | Filing → |
| ANGN | SELL | 2021-08-19 | $3K | — | Filing → |